UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Characterization of Enterobacteriaceae producing OXA-48-like carbapenemases in the UK

Journal of antimicrobial chemotherapy, 2012-07, Vol.67 (7), p.1660-1665

2012

Volltextzugriff (PDF)

The epidemic West Nile virus strain in Greece was a recent introduction

Vector borne and zoonotic diseases (Larchmont, N.Y.), 2013-10, Vol.13 (10), p.719

2013

Volltextzugriff (PDF)

Real world data on the prognostic significance of monocytopenia in myelodysplastic syndrome

Scientific reports, 2022-10, Vol.12 (1), p.17914-17914, Article 17914

2022

Volltextzugriff (PDF)

Micrornas Analysis in Patients with Myelodysplastic Syndrome. Possible Implications in Risk Stratification

Blood, 2022-11, Vol.140 (Supplement 1), p.6958-6959

2022

Volltextzugriff (PDF)

Decreasing Incidence of the Multisystem Inflammatory Syndrome in Children Over 3 Pandemic Waves

The Pediatric infectious disease journal, 2023-02, Vol.42 (2), p.122

2023

Volltextzugriff (PDF)

Serum Procalcitonin Levels in Newly Diagnosed Hodgkin Lymphoma: Correlation with Other Inflammatory Biomarkers

Medicina (Kaunas, Lithuania), 2022-09, Vol.58 (10), p.1331

2022

Volltextzugriff (PDF)

TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in Greece

Medicina (Kaunas, Lithuania), 2021-08, Vol.57 (8), p.827

2021

Volltextzugriff (PDF)

Diversity of saproxylic basidiomycetes in Quercus ilex woodlands of central and insular Greece

Plant biosystems, 2019-05, Vol.153 (3), p.385-397

2019

Volltextzugriff (PDF)

Non-Small Cell Lung Cancer beyond Biomarkers: The Evolving Landscape of Clinical Trial Design

Journal of Personalized Medicine, 2014-06, Vol.4 (3), p.386-401

2014

Volltextzugriff (PDF)

P051: Serum procalcitonin levels in newly diagnosed classical Hodgkin Lymphoma (cHL): Correlation with other inflammatory biomarkers

HemaSphere, 2022-10, Vol.6 (Suppl), p.23-23

2022

Volltextzugriff (PDF)

Identification of Very Low‐Risk Subgroups of Patients with Primary Mediastinal Large B‐Cell Lymphoma Treated with R‐CHOP

The oncologist (Dayton, Ohio), 2021-07, Vol.26 (7), p.597-609

2021

Volltextzugriff (PDF)

Myelodysplastic neoplasm with isolated thrombocytopenia and immune thrombocytopenic purpura in adults: insights from a comparison of two national registries

Leukemia, 2023-03, Vol.37 (3), p.708-711

2023

Volltextzugriff (PDF)

Bone Marrow Ribonucleotide Reductase mRNA Levels and Methylation Status As a Prognostic Factor in Patients with Myelodysplastic Syndrome Treated with 5-Azacytidine

Blood, 2019-11, Vol.134 (Supplement_1), p.1721-1721

2019

Volltextzugriff (PDF)

Myelodysplastic Syndromes (MDS) Presenting with Isolated Thrombocytopenia: Characteristics, Outcomes, and Clinical Presentation Differences from Immune Thrombocytopenic Purpura (ITP)

Blood, 2021-11, Vol.138 (Supplement 1), p.1535-1535

2021

Volltextzugriff (PDF)

Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas

Hematological oncology, 2021-08, Vol.39 (3), p.336-348

2021

Volltextzugriff (PDF)

Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies

Annals of hematology, 2021-09, Vol.100 (9), p.2279-2292

2021

Volltextzugriff (PDF)

Standardization of Epidermal Growth Factor Receptor (EGFR) Measurement by Quantitative Immunofluorescence and Impact on Antibody-Based Mutation Detection in Non–Small Cell Lung Cancer

The American journal of pathology, 2011-08, Vol.179 (2), p.580-589

2011

Volltextzugriff (PDF)

Estimated Glomerular Filtration Rate Is an Independent Predictor of Outcome in High-Risk Myelodysplastic Syndrome (MDS) and Low Blast Count Acute Myeloid Leukaemia (AML) Patients Treated with Azacytidine (AZA). a Retrospective Study from the MDS Registry of the Hellenic MDS Study Group

Blood, 2019-11, Vol.134 (Supplement_1), p.5423-5423

2019

Volltextzugriff (PDF)

Patients with Myelodysplastic Syndromes, Other Than Del(5)q Syndrome, Exhibiting Del(5)q Alone or Associated with One Additional Chromosomal Abnormality Have Comparable Probability and Duration of Response to Lenalidomide, with Patients Classified As Del(5)q Syndrome

Blood, 2017-12, Vol.130, p.1696-1696

2017

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Characterization of Enterobacteriaceae producing OXA-48-like carbapenemases in the UK

The epidemic West Nile virus strain in Greece was a recent introduction

Real world data on the prognostic significance of monocytopenia in myelodysplastic syndrome

Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek population

A Nationwide Study of the Delayed Diagnosis and the Clinical Manifestations of Predominantly Antibody Deficiencies and CTLA4 -Mediated Immune Dysregulation Syndrome in Greece

Micrornas Analysis in Patients with Myelodysplastic Syndrome. Possible Implications in Risk Stratification

Decreasing Incidence of the Multisystem Inflammatory Syndrome in Children Over 3 Pandemic Waves

Serum Procalcitonin Levels in Newly Diagnosed Hodgkin Lymphoma: Correlation with Other Inflammatory Biomarkers

TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in Greece

Diversity of saproxylic basidiomycetes in Quercus ilex woodlands of central and insular Greece

Non-Small Cell Lung Cancer beyond Biomarkers: The Evolving Landscape of Clinical Trial Design

P051: Serum procalcitonin levels in newly diagnosed classical Hodgkin Lymphoma (cHL): Correlation with other inflammatory biomarkers

Autoimmune hemolytic anemia and autoimmune thrombocytopenia at diagnosis and during follow-up of Hodgkin lymphoma

Identification of Very Low‐Risk Subgroups of Patients with Primary Mediastinal Large B‐Cell Lymphoma Treated with R‐CHOP

Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes

Myelodysplastic neoplasm with isolated thrombocytopenia and immune thrombocytopenic purpura in adults: insights from a comparison of two national registries

Bone Marrow Ribonucleotide Reductase mRNA Levels and Methylation Status As a Prognostic Factor in Patients with Myelodysplastic Syndrome Treated with 5-Azacytidine

Myelodysplastic Syndromes (MDS) Presenting with Isolated Thrombocytopenia: Characteristics, Outcomes, and Clinical Presentation Differences from Immune Thrombocytopenic Purpura (ITP)

Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas

A Nationwide Study of the Delayed Diagnosis and the Clinical Manifestations of Predominantly Antibody Deficiencies and ICTLA4/I-Mediated Immune Dysregulation Syndrome in Greece

Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies

Standardization of Epidermal Growth Factor Receptor (EGFR) Measurement by Quantitative Immunofluorescence and Impact on Antibody-Based Mutation Detection in Non–Small Cell Lung Cancer

Estimated Glomerular Filtration Rate Is an Independent Predictor of Outcome in High-Risk Myelodysplastic Syndrome (MDS) and Low Blast Count Acute Myeloid Leukaemia (AML) Patients Treated with Azacytidine (AZA). a Retrospective Study from the MDS Registry of the Hellenic MDS Study Group

Patients with Myelodysplastic Syndromes, Other Than Del(5)q Syndrome, Exhibiting Del(5)q Alone or Associated with One Additional Chromosomal Abnormality Have Comparable Probability and Duration of Response to Lenalidomide, with Patients Classified As Del(5)q Syndrome

Chronic myelomonocytic leukemia treated with 5-azacytidine - results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system

Suchergebnisse filtern